摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-cyclohexanecarbonyl-N-methyl-glycine | 85856-47-9

中文名称
——
中文别名
——
英文名称
N-cyclohexanecarbonyl-N-methyl-glycine
英文别名
N-Cyclohexancarbonyl-N-methyl-glycin;N-(cyclohexylcarbonyl)-N-methylglycine;2-[cyclohexanecarbonyl(methyl)amino]acetic acid
<i>N</i>-cyclohexanecarbonyl-<i>N</i>-methyl-glycine化学式
CAS
85856-47-9
化学式
C10H17NO3
mdl
MFCD09045821
分子量
199.25
InChiKey
SLZWLHCXGUWSJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    57.6
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE
    申请人:Fujita Takashi
    公开号:US20130165446A1
    公开(公告)日:2013-06-27
    The present invention addresses the problem of finding a compound having both PPAR activation activity and angiotensin receptor antagonistic activity. The present invention is a benzo- or pyrido-imidazole derivative represented by general formula (I), a pharmaceutically acceptable salt thereof, or a ester or amide thereof (where A is biphenyl methyl-imidazolyl, biphenyl methyl-benzimidazolyl, or the like, B is divalent benzimidazolyl or the like, C is carboxyl or the like, E is divalent phenyl, naphthyl, or the like, G is a dangling bond, oxygen, or the like, Q is oxygen or sulfur, n is an integer from 1 to 6, p is an integer from 1 to 6, V is a dangling bond, oxygen, or the like, and R is hydrogen, alkyl, or the like).
    本发明解决了寻找既具有PPAR激活活性又具有血管紧张素受体拮抗活性的化合物的问题。本发明是一种由通式(I)表示的苯并或吡啶-咪唑生物,其药学上可接受的盐,或其酯或酰胺(其中A是联苯甲基咪唑基,联苯甲基苯并咪唑基或类似物,B是二价苯并咪唑基或类似物,C是羧基或类似物,E是二价苯基,基或类似物,G是悬键,氧或类似物,Q是氧或,n是从1到6的整数,p是从1到6的整数,V是悬键,氧或类似物,R是氢,烷基或类似物)。
  • WRINKLE-PREVENTIVE/AMELIORATING AGENT
    申请人:SHISEIDO COMPANY, LTD.
    公开号:EP1908454A1
    公开(公告)日:2008-04-09
    A wrinkle-preventing and -improving composition comprising one or more than one compound selected from the group consisting of α-amino acid derivatives represented by the following general formula (1) and salts thereof: wherein, R1 represents hydrogen atom, CH3 group or CH2OH group, R2 and R3 each independently represent hydrogen atom, alkyl group having 1 to 4 carbons, provided that R2 and R3 cannot be hydrogen atom at the same time, or R2 and R3 together with N atom to which they are bound may form a ring structure having a total carbon number of 4 to 6, in which case said ring structure may optionally contain an oxygen atom as a heteroatom, R4 represents hydrogen atom, alkyl group having 1 to 18 carbons, wherein when R1 and R4 are hydrogen atom, it cannot be that one of R2 and R3 is benzyloxycarbonyl group and the other is hydrogen atom.
    一种防皱和改善皱纹的组合物,包含一种或一种以上选自下式(1)所代表的 α-氨基酸生物及其盐类的化合物: 其中,R1 代表氢原子、CH3 基团或 CH2OH 基团,R2 和 R3 各自独立地代表氢原子、具有 1 至 4 个碳原子的烷基,但 R2 和 R3 不能同时为氢原子,或者 R2 和 R3 与它们所结合的 N 原子可形成一个总碳数为 4 至 6 的环结构、R4 代表氢原子或碳原子数为 1 至 18 的烷基,其中当 R1 和 R4 为氢原子时,R2 和 R3 不能一个为苄氧羰基,另一个为氢原子。
  • BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE
    申请人:Fujita, Takashi
    公开号:EP2581373A1
    公开(公告)日:2013-04-17
    The present invention addresses the problem of finding a compound having both PPAR activation activity and angiotensin receptor antagonistic activity. The present invention is a benzo- or pyrido-imidazole derivative represented by general formula (I), a pharmaceutically acceptable salt thereof, or a ester or amide thereof (where A is biphenyl methyl-imidazolyl, biphenyl methyl-benzimidazolyl, or the like, B is divalent benzimidazolyl or the like, C is carboxyl or the like, E is divalent phenyl, naphthyl, or the like, G is a dangling bond, oxygen, or the like, Q is oxygen or sulfur, n is an integer from 1 to 6, p is an integer from 1 to 6, V is a dangling bond, oxygen, or the like, and R is hydrogen, alkyl, or the like).
    本发明要解决的问题是找到一种既具有 PPAR 激活活性又具有血管紧张素受体拮抗活性的化合物。本发明是通式(I)代表的苯并咪唑吡啶咪唑生物、其药学上可接受的盐或其酯或酰胺(其中 A 是联苯甲基咪唑基、联苯甲基苯并咪唑基或类似物,B 是二价苯并咪唑基或类似物、C 是羧基或类似物,E 是二价苯基、基或类似物,G 是悬键、氧或类似物,Q 是氧或,n 是 1 到 6 的整数,p 是 1 到 6 的整数,V 是悬键、氧或类似物,R 是氢、烷基或类似物)。
  • WRINKLE-PREVENTING AND IMPROVING COMPOSITION
    申请人:TSUNENAGA Makoto
    公开号:US20100168468A1
    公开(公告)日:2010-07-01
    A wrinkle-preventing and -improving composition comprising one or more than one compound selected from the group consisting of α-amino acid derivatives represented by the following general formula (1) and salts thereof: wherein, R 1 represents hydrogen atom, CH 3 group or CH 2 OH group, R 2 and R 3 each independently represent hydrogen atom, alkyl group having 1 to 4 carbons, provided that R 2 and R 3 cannot be hydrogen atom at the same time, or R 2 and R 3 together with N atom to which they are bound may form a ring structure having a total carbon number of 4 to 6, in which case said ring structure may optionally contain an oxygen atom as a heteroatom, R 4 represents hydrogen atom, alkyl group having 1 to 18 carbons, wherein when R 1 and R 4 are hydrogen atom, it cannot be that one of R 2 and R 3 is benzyloxycarbonyl group and the other is hydrogen atom.
  • Wrinkle-preventing and improving composition
    申请人:Tsunenaga Makoto
    公开号:US20110065794A1
    公开(公告)日:2011-03-17
    A wrinkle-preventing and -improving composition comprising one or more than one compound selected from the group consisting of α-amino acid derivatives represented by the following general formula (1) and salts thereof: wherein, R 1 represents hydrogen atom, CH 3 group or CH 2 OH group, R 2 and R 3 each independently represent hydrogen atom, alkyl group having 1 to 4 carbons, provided that R 2 and R 3 cannot be hydrogen atom at the same time, or R 2 and R 3 together with N atom to which they are bound may form a ring structure having a total carbon number of 4 to 6, in which case said ring structure may optionally contain an oxygen atom as a heteroatom, R 4 represents hydrogen atom, alkyl group having 1 to 18 carbons, wherein when R 1 and R 4 are hydrogen atom, it cannot be that one of R 2 and R 3 is benzyloxycarbonyl group and the other is hydrogen atom.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸